ICD-10-CM Billable Code

M89.39

Hypertrophy of bone, multiple sites

Clinical Classification Guidelines

Medical Intelligence & Overview

Hypertrophy of bone refers to an abnormal increase in bone size or growth that occurs across multiple locations within the body. This condition involves excessive bone formation, leading to an enlargement of affected bones, which can result in various physical deformities and functional impairments. When it occurs in multiple sites, it indicates a widespread process impacting various bones, often associated with specific underlying health conditions. Understanding the causes, symptoms, diagnosis, and treatment options can help in managing this complex condition effectively.

Causes & Symptoms

Clinical Causes: Genetic disorders characterized by abnormal bone growth Metabolic bone diseases, such as osteopetrosis Chronic inflammatory conditions affecting bones Certain tumors or neoplastic processes leading to abnormal bone proliferation Endocrine disorders influencing bone metabolism Infection-related bone changes

Key Symptoms: Visible swelling or enlargement of multiple bones Localized pain or tenderness in affected areas Decreased joint mobility or stiffness Deformities of bones or limbs Potential neurological symptoms if bones press on nerves Reduced muscle strength around affected sites

Diagnostic & Treatment

Diagnosis Path: Detailed medical history assessment, including family history Physical examination focusing on the distribution and extent of bone enlargements Imaging tests such as X-rays, CT scans, or MRIs to visualize bone changes Laboratory studies to assess bone metabolism and identify underlying causes Bone biopsies if needed to determine tissue characteristics and rule out tumors

Treatment Protocols: Medication therapy, such as bisphosphonates or other drugs to regulate bone growth Surgical intervention to correct deformities or relieve pressure on nerves Physical therapy to improve joint mobility and muscle strength Management of associated conditions or diseases contributing to abnormal bone growth Regular monitoring to assess disease progression and treatment response

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M89.39 a billable ICD-10 code?
Yes, M89.39 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M89.39?
Clinical documentation must specify the nature of Hypertrophy of bone, multiple sites and any associated comorbidities for accurate reporting.

Cite this Clinical Reference